MARKET

PRAH

PRA Health
PRAH
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
54.30
3.232
6.87
10,704,848,034.00
--Mizuho Securities Starts PRA Health Sciences at Neutral with $169 Price Target
MT Newswires · 07/06 10:17
Packaged Air Conditioner Market Worldwide Survey On Product Need 2029
marketwatch.com · 07/02 16:35
Flexible Heater Market Strategic Assessment & SWOT Analysis 2029-2030 | Rogers Corporation, Omega Engineering, Honeywell International Incorporation
marketwatch.com · 07/02 16:35
Ultrasonic Testing Market to Witness Huge Growth by Key Players: Zeal International, Cygnus instruments Incorporation, Amerapex corporation
marketwatch.com · 07/02 16:35
Bone Putty Market Size and Growth Prospects 2019 – 2027
marketwatch.com · 07/02 16:35
Bone Screw System Market Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report 2027
marketwatch.com · 07/02 16:35
Parexel is said near sale to EQT AB and Goldman Sachs for nearly $9B
Zhanna Hapanovich/iStock via Getty Images EQT AB and Goldman Sachs Inc.'s (GS) investment arm are reportedly in advanced discussions to buy contract-research organization Parexel for close to $9B including debt.
Seekingalpha · 07/02 11:04
ICON acquisition creates world-leading healthcare intelligence and clinical research organisation
ICON plc, (NASDAQ: ICLR) ("ICON") today announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world's most advanced heal...
Business Wire · 07/01 12:43
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRAH. Analyze the recent business situations of PRA Health through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRAH stock price target is 166.00 with a high estimate of 170.00 and a low estimate of 160.00.
EPS
Institutional Holdings
Institutions: 515
Institutional Holdings: 65.45M
% Owned: 101.01%
Shares Outstanding: 64.80M
TypeInstitutionsShares
Increased
88
4.57M
New
87
9.30M
Decreased
111
13.17M
Sold Out
52
2.10M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data

Webull offers kinds of PRA Health stock information, including NASDAQ:PRAH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRAH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRAH stock methods without spending real money on the virtual paper trading platform.